Dr. Gabriel Pardo helped develop the new multiple sclerosis medication Kesimpta and spoke about the drug.
approval
Dream team: OMRF, OU join forces to battle the virus
When Covid-19 hit Oklahoma, the state had only minimal testing options available. OMRF and OU joined forces to change that.
OMRF brain tumor drug receives rare disease designations from the FDA
The drug treats fast-growing, deadly brain cancers with no effective treatment.
OU, OMRF file for FDA authorization for COVID-19 detection test utilizing Fluidigm technology
The test is intended for large-scale testing of patients, with the capacity to test 180,000 samples over the next 90 days.
OMRF enters into a license agreement with Shanghai RAAS Blood Products
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
